{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:53:12Z","timestamp":1789408392097,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd008214.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000}}],"reference-count":190,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008214.pub4","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T07:14:16Z","timestamp":1685517256000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy"],"prefix":"10.1002","volume":"2023","author":[{"given":"Panagiotis","family":"Dervenis","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital (City Road); Moorfields Eye Hospital NHS Foundation Trust; London UK"},{"name":"Department of Biostatistics; Faculty of Medicine, University of Thessaly; Larissa Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Dervenis","sequence":"additional","affiliation":[{"name":"1st Department of Ophthalmology; Medical School, Aristotle University of Thessaloniki; Thessaloniki Greece"},{"name":"Institute of Ageing and Chronic Disease; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M","family":"Smith","sequence":"additional","affiliation":[{"name":"Sunderland Eye Infirmary; Sunderland UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David HW","family":"Steel","sequence":"additional","affiliation":[{"name":"Sunderland Eye Infirmary; Sunderland UK"},{"name":"Biosciences Institute; Newcastle University; Newcastle Upon Tyne UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD008214.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.ophtha.2009.07.001","article-title":"Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial","volume":"116","author":"Ahmadieh","year":"2009","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD008214.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.ophtha.2011.03.036","article-title":"The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy","volume":"118","author":"Ahn","year":"2011","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD008214.pub4-BIB0003|cit3","first-page":"1740","article-title":"Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trial","volume":"103","author":"Aleman","year":"2019","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ajo.2019.05.007","article-title":"Preoperative bevacizumab for tractional retinal detachment in proliferative diabetic retinopathy: a prospective randomized clinical trial","volume":"207","author":"Arevalo","year":"2019","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/eye.2017.75","article-title":"Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study)","volume":"31","author":"Comyn","year":"2017","journal-title":"Eye"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"4927259","DOI":"10.1155\/2018\/4927259","article-title":"Efficacy and safety of intravitreal conbercept, ranibizumab, and triamcinolone on 23-gauge vitrectomy for patients with proliferative diabetic retinopathy","volume":"2018","author":"Cui","year":"2018","journal-title":"Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00417-010-1303-3","article-title":"Intravitreal bevacizumab for the surgical treatment of severe proliferative retinopathy","volume":"248","author":"di Lauro","year":"2010","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0008|cit8","first-page":"809","article-title":"Effect of ranibizumab on the efficacy of vitrectomy in patients with PDR","volume":"19","author":"Dong","year":"2019","journal-title":"International Eye Science"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0009|cit9","first-page":"709","article-title":"Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy","volume":"2","author":"El Batarny","year":"2008","journal-title":"Clinical Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD008214.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/IAE.0b013e31820a68e5","article-title":"Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage","volume":"31","author":"Farahvash","year":"2011","journal-title":"Retina"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1590\/S0034-72802013000100003","article-title":"Use of intravitreal bevacizumab or triamcinolone acetonide as a preoperative adjunct to vitrectomy for vitreous haemorrhage in diabetics","volume":"72","author":"Ferraz","year":"2013","journal-title":"Revista Brasileira de Oftalmologia"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/112067211002000604","article-title":"Experience with intravitreal bevacizumab as a preoperative adjunct in 23-G vitrectomy for advanced proliferative diabetic retinopathy","volume":"20","author":"Hern\u00e1ndez-Da Mota","year":"2010","journal-title":"European Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0013|cit13","first-page":"817","article-title":"Effect of ranibizumab injection on the surgical outcome and complications of PDR patients before PPV","volume":"19","author":"Hu","year":"2019","journal-title":"International Eye Science"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12886-020-1321-9","article-title":"The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study","volume":"20","author":"Jiang","year":"2020","journal-title":"BMC Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12886-022-02303-3","article-title":"The efficacy and safety of intravitreal injection of Ranibizumab as pre\u2011treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage","volume":"22","author":"Li","year":"2022","journal-title":"BMC Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/IAE.0000000000000577","article-title":"Randomized controlled study of intravitreal bevacizumab 0.16 mg injected one day before surgery for proliferative diabetic retinopathy","volume":"35","author":"Manabe","year":"2015","journal-title":"Retina"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/112067210901900526","article-title":"Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy","volume":"19","author":"Modarres","year":"2009","journal-title":"European Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0018|cit18","first-page":"986","article-title":"Intravitreal injection of Conbercept combined with PPV in the treatment of proliferative diabetic retinopathy","volume":"21","author":"Ou","year":"2021","journal-title":"International Eye Science"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3928\/23258160-20141118-06","article-title":"A randomized study comparing the efficacy of bevacizumab and ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy","volume":"45","author":"Pakzad-Vaezi","year":"2014","journal-title":"Ophthalmic Surgery, Lasers and Imaging Retina"},{"issue":"7","key":"10.1002\/14651858.CD008214.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41433-019-0396-0","article-title":"Safety and efficacy of intravitreal conbercept injection after vitrectomy for the treatment of proliferative diabetic retinopathy","volume":"33","author":"Ren","year":"2019","journal-title":"Eye"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00417-008-0774-y","article-title":"Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)","volume":"246","author":"Rizzo","year":"2008","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archophthalmol.2012.1611","article-title":"Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1","volume":"130","author":"Sohn","year":"2012","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/IAE.0000000000000900","article-title":"Intravitreal conbercept (KH902) for surgical treatment of severe proliferative diabetic retinopathy","volume":"36","author":"Su","year":"2016","journal-title":"Retina"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0024|cit24","first-page":"1214","article-title":"Aflibercept and bevacizumab injection effects on visual acuity of post vitrectomy diabetic retinopathy","volume":"13","author":"Wildan","year":"2019","journal-title":"Pakistan Journal of Medical and Health Sciences"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"2473234","DOI":"10.1155\/2016\/2473234","article-title":"A randomized controlled trial of conbercept pretreatment before vitrectomy in proliferative diabetic retinopathy","volume":"2016","author":"Yang","year":"2016","journal-title":"Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0026|cit26","first-page":"1402","article-title":"Effect of vitrectomy combined medication hyperplastic on patients with diabetic retinopathy","volume":"15","author":"Yu","year":"2015","journal-title":"International Eye Science"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0027|cit27","first-page":"590","article-title":"Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy","volume":"29","author":"Zaman","year":"2013","journal-title":"Pakistan Journal of Medical Science"},{"issue":"12","key":"10.1002\/14651858.CD008214.pub4-BIB0028|cit28","first-page":"2321","article-title":"Clinical effect of 25G+ vitrectomy combined with intravitreal injection of conbercept in the treatment of severe proliferative diabetic retinopathy","volume":"17","author":"Zhou","year":"2017","journal-title":"International Eye Science"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12886-020-01401-4","article-title":"Intravitreal aflibercept injection with panretinal photocoagulation versus early vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial","volume":"20","author":"Abd Elhamid","year":"2020","journal-title":"BMC Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000314721","article-title":"Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series","volume":"45","author":"Abdelhakim","year":"2011","journal-title":"Ophthalmic Research"},{"issue":"13","key":"10.1002\/14651858.CD008214.pub4-BIB0031|cit31","first-page":"ARVO E","article-title":"Comparative, randomized, double blinded study of the use of anti-VEGF in patients with vitreous hemorrhage or tractional retinal detachment secondary to diabetic retinopathy","volume":"55","author":"Albuquerque","year":"2014","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"23","key":"10.1002\/14651858.CD008214.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2020.23027","article-title":"Effect of intravitreous aflibercept vs vitrectomy with panretinal photocoagulation on visual acuity in patients with vitreous hemorrhage from proliferative diabetic retinopathy: a randomized clinical trial","volume":"324","author":"Antoszyk","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0033|cit33","first-page":"ARVO E","article-title":"Initial aflibercept versus vitrectomy with panretinal photocoagulation for vitreous hemorrhage (VH) from proliferative diabetic retinopathy (PDR): a DRCR retina network randomized clinical trial","volume":"62","author":"Antoszyk","year":"2021","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/08820538.2013.835847","article-title":"The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage","volume":"30","author":"Berk Ergun","year":"2015","journal-title":"Seminars in Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD008214.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jamaophthalmol.2014.287","article-title":"Evaluation of results 1 year following short-term use of ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathy","volume":"132","author":"Bhavsar","year":"2014","journal-title":"JAMA Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2017.08.013","article-title":"Preoperative bevacizumab administration in proliferative diabetic retinopathy patients undergoing vitrectomy: a randomized and controlled trial comparing interval variation","volume":"183","author":"Castillo","year":"2017","journal-title":"American Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD008214.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.oret.2018.04.014","article-title":"Bevacizumab before diabetic vitrectomy: a clinical trial assessing 3 dosing amounts","volume":"2","author":"Castillo Velazquez","year":"2018","journal-title":"Ophthalmology Retina"},{"issue":"11","key":"10.1002\/14651858.CD008214.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.4103\/ijo.IJO_1264_21","article-title":"Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment - a quasi-randomized retrospective study","volume":"69","author":"Chakraborty","year":"2021","journal-title":"Indian Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10792-019-01244-z","article-title":"Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study","volume":"40","author":"Chatziralli","year":"2020","journal-title":"International Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD008214.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/IAE.0b013e3181d6def0","article-title":"Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage","volume":"30","author":"Cheema","year":"2010","journal-title":"Retina"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/IAE.0000000000001673","article-title":"Efficacy of intravitreal ranibizumab injections in the treatment of vitreous hemorrhage related to proliferative diabetic retinopathy","volume":"38","author":"Chelala","year":"2018","journal-title":"Retina"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.21037\/apm.2020.01.10","article-title":"Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy","volume":"9","author":"Chen","year":"2020","journal-title":"Annals of Palliative Medicine"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub4-BIB0043|cit43","first-page":"ARVO E","article-title":"Vitreous and plasma cytokine levels in subjects with advanced proliferative diabetic retinopathy in the Ranibizumab in Diabetic Vitrectomy (RaDiVit) Study","volume":"60","author":"Comyn","year":"2019","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bjo.2008.151233","article-title":"Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study)","volume":"93","author":"da R Lucena","year":"2009","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4137\/OED.S12352","article-title":"Effect of bevacizumab injection before vitrectomy on intravitreal hemorrhage in pseudophakic patients with proliferative diabetic retinopathy","volume":"5","author":"Demir","year":"2013","journal-title":"Ophthalmology and Eye Diseases"},{"issue":"13","key":"10.1002\/14651858.CD008214.pub4-BIB0046|cit46","first-page":"ARVO E","article-title":"Intravitreal ranibizumab for vitreous hemorrhage in proliferative diabetic retinopathy","volume":"55","author":"Dirani","year":"2014","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0047|cit47","first-page":"310","article-title":"The effect on surgical success of intravitreal bevacizumab given before pars plana vitrectomy in diabetic patients","volume":"18","author":"Doganay","year":"2010","journal-title":"Retina-Vitreus"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0048|cit48","unstructured":"Elwan MM Ghanem AA Abousamra WA Outcome of a single intravitreal bevacizumab injection on the visual acuity and course of pars plana vitrectomy in proliferative diabetic retinopathy\u00a0 Current Eye Research"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000493640","article-title":"Preoperative timing of intravitreal bevacizumab injection for proliferative diabetic retinopathy patients","volume":"60","author":"Feng","year":"2018","journal-title":"Ophthalmic Research"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcjo.2015.11.001","article-title":"Alterations in intraocular cytokine levels following intravitreal ranibizumab","volume":"51","author":"Forooghian","year":"2016","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/jop.2019.0149","article-title":"Intravitreal conbercept injection as an adjuvant in vitrectomy with silicone oil infusion for severe proliferative diabetic retinopathy","volume":"36","author":"Gao","year":"2020","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5301\/ejo.5000327","article-title":"The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage","volume":"24","author":"Goncu","year":"2014","journal-title":"European Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0053|cit53","first-page":"252","article-title":"Preoperative intravitreal bevacizumab improves visual outcome in diabetic vitreous surgery","author":"Gupta","year":"2008","journal-title":"American Academy of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/eye.2011.321","article-title":"Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK study","volume":"26","author":"Gupta","year":"2012","journal-title":"Eye"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10792-012-9541-5","article-title":"Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab","volume":"32","author":"Gupta","year":"2012","journal-title":"International Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"728","DOI":"10.29271\/jcpsp.2019.08.728","article-title":"Visual outcomes of pars plana vitrectomy alone or with intravitreal bevacizumab in patients of diabetic vitreous haemorrhage","volume":"29","author":"Haseeb","year":"2019","journal-title":"Journal of the College of Physicians and Surgeons - Pakistan"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s10792-021-01703-6","article-title":"Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy","volume":"41","author":"Hu","year":"2021","journal-title":"International Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"e726","DOI":"10.1111\/aos.14957","article-title":"Monitoring intraocular proangiogenic and profibrotic cytokines within 7 days after adjunctive anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy","volume":"100","author":"Hu","year":"2022","journal-title":"Acta Ophthalmologica"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.eye.6702983","article-title":"Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy","volume":"23","author":"Ishikawa","year":"2009","journal-title":"Eye"},{"issue":"13","key":"10.1002\/14651858.CD008214.pub4-BIB0060|cit60","first-page":"ARVO E","article-title":"Angiofibrotic response to bevacizumab on fibrovascular membranes in proliferative diabetic retinopathy","volume":"55","author":"Jiao","year":"2014","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"42","key":"10.1002\/14651858.CD008214.pub4-BIB0061|cit61","first-page":"6805","article-title":"Changes of cytokines in the aqueous humor following avastin intravitreous injection","volume":"18","author":"Jin-An","year":"2014","journal-title":"Chinese Journal of Tissue Engineering Research"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008214.pub4-BIB0062|cit62","first-page":"S136","article-title":"Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study","volume":"95","author":"Jirawison","year":"2012","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40942-021-00296-7","article-title":"Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial","volume":"7","author":"Jorge","year":"2021","journal-title":"International Journal of Retina and Vitreous"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/1874364102115010137","article-title":"Anti-vascular endothelial growth factor therapy as an adjunct to diabetic vitrectomy","volume":"15","author":"Karimov","year":"2021","journal-title":"Open Ophthalmology Journal"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0065|cit65","first-page":"ARVO E","article-title":"Complications, compliance and 3-year outcomes after endolaserless vitrectomy with aflibercept monotherapy for PDR-related vitreous hemorrhage","volume":"62","author":"Kasetty","year":"2021","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"15","key":"10.1002\/14651858.CD008214.pub4-BIB0066|cit66","first-page":"ARVO E","article-title":"Post-operative hemorrhage after vitrectomy for proliferative diabetic retinopathy with or without pre-surgical intravitreal bevacizumab","volume":"54","author":"Kawano","year":"2013","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"13","key":"10.1002\/14651858.CD008214.pub4-BIB0067|cit67","first-page":"ARVO E","article-title":"Intravitreal aflibercept as a surgical adjuvant in severe proliferative diabetic retinopathy","volume":"55","author":"Leonard","year":"2014","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0068|cit68","first-page":"261","article-title":"Effect of intravitreal bevacizumab injection before vitrectomy on proliferative diabetic retinopathy","volume":"3","author":"Li","year":"2010","journal-title":"International Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0069|cit69","first-page":"1202","article-title":"Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab","volume":"8","author":"Li","year":"2015","journal-title":"International Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD008214.pub4-BIB0070|cit70","first-page":"1959","article-title":"Effect of ranibizumab intravitreal injection before 23G-vitrectomy surgery in the treatment of patients with proliferative diabetic retinopathy","volume":"16","author":"Li","year":"2016","journal-title":"International Eye Science"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/CM9.0000000000000687","article-title":"Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy","volume":"133","author":"Li","year":"2020","journal-title":"Chinese Medical Journal"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub4-BIB0072|cit72","first-page":"ARVO E","article-title":"Day regimes of CONbercept on cytokinEs of PDR patients undergoing vitrectomy trial (CONCEPT): effects of preoperative intravitreal conbercept on cytokines in the vitreous with proliferative diabetic retinopathy","volume":"60","author":"Liu","year":"2019","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"7","key":"10.1002\/14651858.CD008214.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/IAE.0b013e3181a8eb88","article-title":"Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (Avastin)","volume":"29","author":"Lo","year":"2009","journal-title":"Retina"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0074|cit74","first-page":"111","article-title":"Clinical effect of intravitreal injection of ranibizumab for severe proliferative diabetic retinopathy","volume":"16","author":"Ma","year":"2016","journal-title":"International Eye Science"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0075|cit75","first-page":"ARVO E","article-title":"Endolaserless vitrectomy with intravitreal aflibercept injection (IAI) for proliferative diabetic retinopathy (PDR)-related vitreous hemorrhage (LASER LESS TRIAL)","volume":"58","author":"Marcus","year":"2017","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0076|cit76","first-page":"972","article-title":"Effect of intravitreal injection of bevacizumab for vitreous hemorrhage in patients with proliferative diabetic retinopathy","volume":"16","author":"Meng","year":"2016","journal-title":"International Eye Science"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0077|cit77","unstructured":"A phase III randomized 1:1, masked, study of the safety, tolerability, and efficacy of intravitreal pre-op 0.3mg pegaptanib sodium versus sham, for adjuvant management of TRD and vit hem associated with PDR clinicaltrials.gov\/show\/NCT01589718"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ophtha.2008.11.005","article-title":"Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment","volume":"116","author":"Oshima","year":"2009","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00417-021-05515-3","article-title":"Comparison of before versus after intravitreal bevacizumab injection, growth factor levels and fibrotic markers in vitreous samples from patients with proliferative diabetic retinopathy","volume":"260","author":"Ozer","year":"2022","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"Suppl","key":"10.1002\/14651858.CD008214.pub4-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1755-3768.2017.02313","article-title":"Vitrectomy with fibrovascular membrane delamination for proliferative diabetic retinopathy with or without preoperative Avastin","volume":"20","author":"Papavasileiou","year":"2017","journal-title":"Hellenic Journal of Nuclear Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00417-009-1247-7","article-title":"Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study","volume":"248","author":"Park","year":"2010","journal-title":"Graefes Archive for Clinical and Experimental Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD008214.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1038\/s41433-020-01384-y","article-title":"Efficacy of bevacizumab for vitreous haemorrhage in proliferative diabetic retinopathy with prior complete panretinal photocoagulation","volume":"35","author":"Park","year":"2021","journal-title":"Eye"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/eye.2011.149","article-title":"Bevacizumab prior to vitrectomy for diabetic traction retinal detachment","volume":"28","author":"Pokroy","year":"2011","journal-title":"Eye"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/eye.2008.354","article-title":"Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?","volume":"23","author":"Romano","year":"2009","journal-title":"Eye"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/112067210901900416","article-title":"Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage?","volume":"19","author":"Romano","year":"2009","journal-title":"European Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/0974-9233.106387","article-title":"Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy","volume":"20","author":"Sato","year":"2013","journal-title":"Middle East African Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0087|cit87","first-page":"852","article-title":"Clinical study of conbercept in patients with proliferative diabetic retinopathy undergoing vitrectomy","volume":"20","author":"Shi","year":"2020","journal-title":"International Eye Science"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub4-BIB0088|cit88","first-page":"ARVO E","article-title":"Endolaserless vitrectomy with intravitreal aflibercept injection (IAI) for proliferative diabetic retinopathy (PDR)-related vitreous hemorrhage: LASER LESS TRIAL 1-year results","volume":"60","author":"Starnes","year":"2019","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0089|cit89","first-page":"1051","article-title":"Effects of Bevacizumab on CTGF and PEDF in proliferative membrane in patients with PDR","volume":"17","author":"Sun","year":"2017","journal-title":"International Eye Science"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"846003","DOI":"10.3389\/fphys.2022.846003","article-title":"Vitreous inflammatory cytokines and chemokines, not altered after preoperative adjunctive conbercept injection, but associated with early postoperative macular edema in patients with proliferative diabetic retinopathy","volume":"13","author":"Sun","year":"2022","journal-title":"Frontiers in Physiology"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2147\/OPTH.S203921","article-title":"Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy","volume":"13","author":"Tsubota","year":"2019","journal-title":"Clinical Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/08820538.2021.1900287","article-title":"Intravitreal ranibizumab versus aflibercept for diabetic macular edema in vitrectomized eyes: 12 month results","volume":"36","author":"Turkseven Kumral","year":"2021","journal-title":"Seminars in Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.13181\/mji.v23i2.756","article-title":"Effect of laser photocoagulation and bevacizumab intravitreal in proliferative diabetic retinopathy: review on biomarkers of oxidative stress","volume":"23","author":"Victor","year":"2014","journal-title":"Medical Journal of Indonesia"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0094|cit94","first-page":"79","article-title":"Comparative clinical and ultrastructural analysis of the results from ranibizumab and aflibercept in patients with PDR","volume":"237","author":"Vidinova","year":"2020","journal-title":"Klinische Monatsblatter fur Augenheilkunde"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0095|cit95","first-page":"e902","article-title":"Effect of intravitreal conbercept treatment on the expression of long noncoding RNAs and mRNAs in proliferative diabetic retinopathy patients","volume":"97","author":"Wang","year":"2019","journal-title":"Acta Opthalmologica"},{"issue":"7","key":"10.1002\/14651858.CD008214.pub4-BIB0096|cit96","first-page":"1158","article-title":"Changes of vitreous cytokine levels in eyes with PDR after intravitreal injection of ranibizumab or triamcinolone acetonide","volume":"20","author":"Wang","year":"2020","journal-title":"International Eye Science"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajo.2008.04.028","article-title":"Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy","volume":"146","author":"Yang","year":"2008","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/IAE.0b013e3181a3b7ef","article-title":"Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy","volume":"29","author":"Yeh","year":"2009","journal-title":"Retina"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1442-9071.2008.01805.x","article-title":"Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series","volume":"36","author":"Yeoh","year":"2008","journal-title":"Clinical and Experimental Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1755-3768.2008.01498.x","article-title":"Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment","volume":"88","author":"Yeung","year":"2010","journal-title":"Acta Opthalmologica"},{"issue":"7","key":"10.1002\/14651858.CD008214.pub4-BIB0101|cit101","first-page":"1300","article-title":"Efficacy comparison of conbercept and ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy","volume":"17","author":"Yin","year":"2017","journal-title":"International Eye Science"},{"issue":"10","key":"10.1002\/14651858.CD008214.pub4-BIB0102|cit102","first-page":"920","article-title":"Effects of intravitreal injection of conbercept on vitrectomy for proliferative diabetic retinopathy","volume":"35","author":"Zeng","year":"2017","journal-title":"Chinese Journal of Experimental Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s13300-018-0527-9","article-title":"Concentrations of VEGF and PlGF decrease in eyes after intravitreal conbercept injection","volume":"9","author":"Zhou","year":"2018","journal-title":"Diabetes Therapy"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0104|cit104","first-page":"363","article-title":"Effects of vitrectomy with preoperative intravitreal conbercept for proliferative diabetic retinopathy","volume":"18","author":"Zhou","year":"2018","journal-title":"International Eye Science"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0105|cit105","unstructured":"A randomised, single-masked, phase IV pilot study of the efficacy and safety of adjunctive intravitreal Avastin\u00ae (bevacizumab) in the prevention of early postoperative vitreous haemorrhage following diabetic vitrectomy www.controlled-trials.com\/ISRCTN79120387"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0106|cit106","unstructured":"Evaluation of ranibizumab in proliferative diabetic retinopathy (PDR) requiring vitrectomy clinicaltrials.gov\/ct2\/show\/NCT00516464"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0107|cit107","unstructured":"Randomized, double blinded, controlled, two-center study assessing the safety and efficacy of intravitreal ranibizumab as a preoperative adjunct treatment before vitrectomy surgery in proliferative diabetic retinopathy (PDR) compared to vitrectomy alone clinicaltrials.gov\/show\/NCT00931125"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0108|cit108","unstructured":"Adjuvant intravitreal bevacizumab in pars plana vitrectomy for vitreous hemorrhage secondary to diabetic retinopathy clinicaltrials.gov\/show\/NCT01091896"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0109|cit109","unstructured":"Adjuvant intravitreal bevacizumab in pars plana vitrectomy for diabetic vitreous hemorrhage clinicaltrials.gov\/show\/NCT01151722"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0110|cit110","unstructured":"A prospective, randomised controlled trial of ranibizumab pre-treatment in diabetic vitrectomy - a pilot study clinicaltrials.gov\/show\/NCT01306981"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0161-6420(85)34002-2","article-title":"Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report #1","volume":"92","year":"1985","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD008214.pub4-BIB0112|cit112","first-page":"862","article-title":"Complications of vitrectomy for non-clearing vitreous hemorrhage in diabetic patients","volume":"19","author":"Benson","year":"1988","journal-title":"Ophthalmic Surgery"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-016-0787-6","article-title":"Surgery for diabetic eye complications","volume":"16","author":"Berrocal","year":"2016","journal-title":"Current Diabetes Reports"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0161-6420(00)00213-X","article-title":"Ultrasound biomicroscopy of sclerotomy sites after pars plana vitrectomy for diabetic vitreous hemorrhage","volume":"107","author":"Bhende","year":"2000","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0161-6420(85)34015-0","article-title":"Long-term diabetic vitrectomy results. Report of 10 year follow-up","volume":"92","author":"Blankenship","year":"1985","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0161-6420(86)33791-6","article-title":"Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy","volume":"93","author":"Blankenship","year":"1986","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archopht.1992.01080160084037","article-title":"Reoperation following diabetic vitrectomy","volume":"110","author":"Brown","year":"1992","journal-title":"Archives of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/aos.14604","article-title":"Silicone oil in vitreoretinal surgery: indications, complications, new developments and alternative long-term tamponade agents","volume":"99","author":"Chen","year":"2021","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1167\/iovs.07-1132","article-title":"Report from the NEI\/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium","volume":"49","author":"Csaky","year":"2008","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1475-1313.2004.00187.x","article-title":"Psychometric properties of vision-related quality of life questionnaires: a systematic review","volume":"24","author":"Boer","year":"2004","journal-title":"Ophthalmic & Physiological Optics"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"251584142110592","DOI":"10.1177\/25158414211059256","article-title":"Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review","volume":"13","author":"Dervenis","year":"2021","journal-title":"Therapeutic Advances in Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.oret.2022.01.023","article-title":"Intraocular tamponade choice with vitrectomy and internal limiting membrane peeling for idiopathic macular hole: a systematic review and meta-analysis","volume":"6","author":"Dervenis","year":"2022","journal-title":"Ophthalmology. Retina"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0123|cit123","unstructured":"Diabetes UK Diabetes: facts and stats www.diabetes.org.uk\/professionals\/position-statements-reports\/statistics\/diabetes-prevalence-2019"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0124|cit124","first-page":"343","article-title":"Strategies for dealing with missing data in clinical trials: from design to analysis","volume":"86","author":"Dziura","year":"2013","journal-title":"Yale Journal of Biology and Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ophtha.2010.08.038","article-title":"Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications","volume":"118","author":"El-Sabagh","year":"2011","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub4-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/IAE.0b013e31817d5be3","article-title":"Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial","volume":"28","author":"Faghihi","year":"2008","journal-title":"Retina"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0127|cit127","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"e1600","DOI":"10.1111\/aos.15144","article-title":"Air versus fluorinated gas tamponades in pars plana vitrectomy treatment for primary rhegmatogenous retinal detachment","volume":"100","author":"Govers","year":"2022","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0129|cit129","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/eye.2011.321","article-title":"Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK study","volume":"26","author":"Gupta","year":"2012","journal-title":"Eye"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00006982-199111030-00007","article-title":"Outpatient fluid-air exchange for severe postvitrectomy diabetic vitreous hemorrhage. Long-term results and complications","volume":"11","author":"Han","year":"1991","journal-title":"Retina"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ophtha.2003.08.043","article-title":"Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings","volume":"111","author":"Hershberger","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0133|cit133","unstructured":"Higgins JPT Altman DG \u00a0Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0134|cit134","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0039-6257(92)90137-I","article-title":"Vitrectomy in the management of diabetic eye disease","volume":"37","author":"Ho","year":"1992","journal-title":"Survey of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00006982-200001000-00010","article-title":"Ultrasound biomicroscopy for examination of the sclerotomy site in eyes with proliferative diabetic retinopathy after vitrectomy","volume":"20","author":"Hotta","year":"2000","journal-title":"Retina"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00417-013-2479-0","article-title":"Clinical and histological features of epiretinal membrane after diabetic vitrectomy","volume":"252","author":"Hsu","year":"2014","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12886-019-1179-x","article-title":"Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab","volume":"19","author":"Hu","year":"2019","journal-title":"BMC Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0161-6420(80)35116-6","article-title":"Diabetic traction retinal detachment. Factors influencing final visual acuity","volume":"87","author":"Hutton","year":"1980","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/OPTH.S16414","article-title":"Comparison of retinal breaks observed during 23 gauge transconjunctival vitrectomy versus conventional 20 gauge surgery for proliferative diabetic retinopathy","volume":"2011","author":"Issa","year":"2011","journal-title":"Clinical Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamaophthalmol.2015.4587","article-title":"The Royal College of Ophthalmologists' national ophthalmology database study of vitreoretinal surgery: report 6, diabetic vitrectomy","volume":"134","year":"2016","journal-title":"JAMA Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD008214.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0161-6420(89)32649-2","article-title":"Hemostatic effects of air versus fluid in diabetic vitrectomy","volume":"96","author":"Joondeph","year":"1989","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub4-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1097\/01.iae.0000246884.76018.63","article-title":"Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study)","volume":"26","author":"Jorge","year":"2006","journal-title":"Retina"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9394(99)00322-0","article-title":"One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy","volume":"129","author":"Kaiser","year":"2000","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years","volume":"102","author":"Klein","year":"1984","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archopht.1984.01040030405011","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years","volume":"102","author":"Klein","year":"1984","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-0420.2001.079001034.x","article-title":"Hemostatic effects of SF6 after diabetic vitrectomy for vitreous hemorrhage","volume":"79","author":"Koutsandrea","year":"2001","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00006982-199313040-00012","article-title":"Wound complications in pars plana vitrectomy","volume":"13","author":"Kreiger","year":"1993","journal-title":"Retina"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0149|cit149","volume-title":"Vitreous","author":"Kroll","year":"2014"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00139341","article-title":"Effect of tranexamic acid on postvitrectomy haemorrhage in diabetic patients","volume":"10","author":"Laatikainen","year":"1987","journal-title":"International Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0151|cit151","first-page":"2","article-title":"A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010","volume":"12","author":"Liew","year":"2014","journal-title":"BMJ Open"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0002-9394(14)74219-9","article-title":"Intraoperative argon endophotocoagulation for recurrent vitreous hemorrhage after vitrectomy for diabetic retinopathy","volume":"103","author":"Liggett","year":"1987","journal-title":"American Journal of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD008214.pub4-BIB0153|cit153","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National Eye Institute Visual Function Questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9394(14)71858-6","article-title":"Efficacy of fluid-air exchange for postvitrectomy diabetic vitreous hemorrhage","volume":"114","author":"Martin","year":"1992","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0155|cit155","first-page":"133","article-title":"The role of vitrectomy in diabetic retinopathy","volume":"18","author":"Mason","year":"1978","journal-title":"International Ophthalmology Clinics"},{"issue":"Pt 2","key":"10.1002\/14651858.CD008214.pub4-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/eye.1991.40","article-title":"Microsurgical management of neovascularisation secondary to posterior segment ischaemia","volume":"5","author":"McLeod","year":"1991","journal-title":"Eye"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bjo.84.8.810","article-title":"Entry site neovascularisation after diabetic vitrectomy","volume":"84","author":"McLeod","year":"2000","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0161-6420(02)01872-9","article-title":"Wieger's ligament [republished in Ophthalmology. 2003 Jun;110(6):1265]","volume":"110","author":"McLeod","year":"2003","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1159\/000509878","article-title":"The effect of internal limiting membrane cleaning on epiretinal membrane formation after vitrectomy for proliferative diabetic retinopathy","volume":"243","author":"Mehta","year":"2020","journal-title":"Ophthalmologica"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/2474126417721774","article-title":"The role of perioperative anti-VEGF during vitrectomy for vitreous hemorrhage in relation to postoperative nonclearing vitreous hemorrhage and cystoid macular edema","volume":"1","author":"Nagbal","year":"2017","journal-title":"Journal of VitreoRetinal Diseases"},{"issue":"12","key":"10.1002\/14651858.CD008214.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0161-6420(84)34099-4","article-title":"Vitreous hemorrhage after vitrectomy for diabetic retinopathy","volume":"91","author":"Novak","year":"1984","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD008214.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0161-6420(89)32686-8","article-title":"Procoagulant effects of intraocular sodium hyaluronate (Healon) after phakic diabetic vitrectomy. A prospective, randomized study","volume":"96","author":"Packer","year":"1989","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bjo.2004.062638","article-title":"Effect of tranexamic acid on early postvitrectomy diabetic haemorrhage; a randomised clinical trial","volume":"89","author":"Ramezani","year":"2005","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0164|cit164","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2023"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ajo.2022.06.015","article-title":"Gas tamponade for the prevention of postoperative vitreous hemorrhaging after diabetic vitrectomy: a randomized clinical trial","volume":"242","author":"Rush","year":"2022","journal-title":"American Journal of Ophthalmology"},{"issue":"11","key":"10.1002\/14651858.CD008214.pub4-BIB0166|cit166","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/jcm8111960","article-title":"Incidence and risk factors for tractional macular detachment after anti-vascular endothelial growth factor agent pretreatment before vitrectomy for complicated proliferative diabetic retinopathy","volume":"8","author":"Russo","year":"2019","journal-title":"Journal of Clinical Medicine"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0021-5155(99)00194-X","article-title":"Neovascularization from scleral wound as cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy","volume":"44","author":"Sawa","year":"2000","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/jms.2008.008015","article-title":"The English national screening programme for sight threatening diabetic retinopathy","volume":"15","author":"Scanlon","year":"2008","journal-title":"Journal of Medical Screening"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ophtha.2006.08.017","article-title":"Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes","volume":"114","author":"Schiff","year":"2007","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0161-6420(96)30697-0","article-title":"Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment","volume":"103","author":"Schwatz","year":"1996","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0161-6420(96)30716-1","article-title":"Diabetic vitreopathy","volume":"103","author":"Sebag","year":"1996","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ophtha.2007.08.034","article-title":"Entry site neovascularization and vitreous cavity hemorrhage after diabetic vitrectomy. The predictive value of inner sclerostomy site ultrasonography","volume":"115","author":"Steel","year":"2008","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD008214.pub4-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00417-008-0980-7","article-title":"Physiology of vitreous surgery","volume":"247","author":"Stefansson","year":"2009","journal-title":"Graefes Archives of Clinical and Experimental Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD008214.pub4-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/IAE.0000000000001316","article-title":"Responsiveness of the National Eye Institute Visual Function Questionnaire-25 to visual acuity gains in patients with diabetic macular edema: Evidence from the RIDE and RISE Trials","volume":"37","author":"Suner","year":"2017","journal-title":"Retina"},{"issue":"10","key":"10.1002\/14651858.CD008214.pub4-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0161-6420(89)32700-X","article-title":"Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy","volume":"96","author":"Tolentino","year":"1989","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/09286586.2014.906628","article-title":"Rate of diabetic vitrectomy in a defined geographical part of North East England","volume":"21","author":"Vaideanu","year":"2014","journal-title":"Ophthalmic Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD008214.pub4-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"e6052","DOI":"10.5867\/medwave.2014.11.6052","article-title":"Does preoperative intravitreal bevacizumab reduce complications of vitrectomy for proliferative diabetic retinopathy?","volume":"14","author":"Veliz","year":"2014","journal-title":"Medwave"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3928\/1542-8877-20010501-04","article-title":"Postoperative complications following vitrectomy for proliferative diabetic retinopathy with sew-on and noncontact wide-angle viewing lenses","volume":"32","author":"Virata","year":"2001","journal-title":"Ophthalmic Surgery and Lasers"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/bjo.84.8.822","article-title":"Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy","volume":"84","author":"West","year":"2000","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ophtha.2006.07.047","article-title":"Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy","volume":"114","author":"Yang","year":"2007","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD008214.pub4-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ophtha.2005.07.010","article-title":"Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study","volume":"112","author":"Yeh","year":"2005","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD008214.pub4-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bjo.2007.124495","article-title":"Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy","volume":"92","author":"Yorston","year":"2008","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD008214.pub4-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2147\/OPTH.S141821","article-title":"Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathy","volume":"11","author":"Yoshida","year":"2017","journal-title":"Clinical Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajo.2013.02.008","article-title":"Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta-analysis of randomized controlled trials","volume":"156","author":"Zhang","year":"2013","journal-title":"American Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD008214.pub4-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1136\/bjo.2010.189514","article-title":"A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy","volume":"95","author":"Zhao","year":"2011","journal-title":"British Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD008214.pub4-BIB0186|cit186","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1111\/aos.14293","article-title":"A relatively higher intraocular pressure set at the end of vitrectomy is associated with a more stable and rapid visual recovery for patients with vitreous haemorrhage","volume":"98","author":"Zhou","year":"2020","journal-title":"Acta Ophthalmologica"},{"issue":"10","key":"10.1002\/14651858.CD008214.pub4-BIB0187|cit187","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.ophtha.2008.04.023","article-title":"Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization","volume":"115","author":"Zhu","year":"2008","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD008214.pub4-BIB0188|cit188","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008214.pub2","article-title":"Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy","author":"Smith","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD008214.pub4-BIB0189|cit189","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008214.pub3","article-title":"Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy","author":"Smith","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008214.pub4-BIB0190|cit190","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008214","article-title":"Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy","author":"Steel","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T03:18:58Z","timestamp":1732504738000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008214.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":190,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008214.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]}}}